Bezos, Gates-backed brain implant startup testing mind-controlled computing on humans IANS Updated: February 21st, 2023, 07:20 IST in Sci-Tech 0 Pic- IANS Share on Facebook Share on Twitter Share on WhatsApp Share on Linkedin San Francisco: US-based brain interface startup, Synchron, backed by Amazon founder Jeff Bezos and Microsoft co-founder Bill Gates, is working on technology designed to transform daily life for people with paralysis. Synchron is part of an emerging crop of companies testing technology in the brain-computer interface industry, reports CNBC. The Synchron Switch is implanted through the blood vessels and allows patients to operate technology using only their minds.
So far, the experimental technology has been tested on three patients in the US and four in Australia, according to the report. “I’ve seen moments between patient and partner, or patient and spouse, where it’s incredibly joyful and empowering to have regained an ability to be a little bit more independent than before. It helps them engage in ways that we take for granted,” Synchron CEO Tom Oxley was quoted as saying.
Synchron, founded in 2012, is a member of the burgeoning brain-computer interface (BCI) industry, the report said. A BCI system decodes brain signals and converts them into commands for external technologies. As per the report, Synchron BCI is inserted through the blood vessels, which Oxley refers to as the “natural highways” into the brain.
Stentrode, a Synchron stent, is fitted with tiny sensors and delivered to a large vein near the motor cortex. The Stentrode is linked to an antenna that sits under the skin in the chest and collects raw brain data that it sends out of the body to external devices, the report added. Synchron’s technology can help patients with severe paralysis or degenerative diseases like amyotrophic lateral sclerosis (ALS), regain their ability to communicate with friends, family, and the outside world, whether through typing, texting, or even accessing social media.
In December last year, the company announced a $75 million funding round, with participation from the investment firms of Gates and Bezos. The US Food and Drug Administration granted Synchron the Breakthrough Device designation in August 2020, which is reserved for medical devices that have the potential to improve treatment for debilitating or life-threatening conditions. The company has yet to generate revenue, and a spokesperson said that Synchron will not comment on how much the procedure will eventually cost, the report stated.
IANS Tags: Bill gates Computing Jeff Bezos mind startup Share Tweet Send Share Suggest A Correction Enter your email to get our daily news in your inbox. Leave this field empty if you're human: Related Posts India needs Rs 33,750 cr to achieve PLI target of setting up 50 GWh of lithium-ion cell, battery mfg plants: Study February 21, 2023 YouTube starts testing new tools for podcasts February 21, 2023 South Korea plans to launch 6G network service in 2028 February 20, 2023 1st-gen iPhone sold for record-breaking $63K at auction February 20, 2023 TRAI to issue consultation paper on digital inclusion; devices, connectivity, literacy to be key focus February 20, 2023 80% of Indian firms face cyber attacks due to miscommunication in IT security February 20, 2023 Leave a Reply Cancel reply Your email address will not be published. Required fields are marked * Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Δ.
